Skip to main content
. 2021 Jul 12;8:709683. doi: 10.3389/fnut.2021.709683

Table 1.

Cohort characteristics.

References Country Design Mode of intervention Subjects Sex Age Duration Type Outcomes
T/C M/F T C
Aliasghari et al. (12) Iran Comparative, double arm Ramadan fasting, 15–16 h a day 42/41 57/26 37.59 (7.06) 35.80 (7.33) 30 d Religious BW, BMI, WC, FBS/GLU, HOMA-IR, FINS
Non-fasting
Cai et al. (13) China RCT Time-restricted feeding, 16 h a day 95/79 29/66 35.52 (5.48) 34.54 (6.96) 12 week Modern BW, BMI, WC, FBS/GLU, TG, TC, LDL-C, HDL-C, liver stiffness
Non-fasting
Cai et al. (13)* China RCT Alternate-day fasting, 22 h a day 90/79 35/60 35.52 (5.48) 34.54 (6.96) 12 week Modern BW, BMI, WC, FBS/GLU, TG, TC, LDL-C, HDL-C, liver stiffness
Non-fasting
Mari et al. (16) Israel Comparative, double arm Ramadan fasting, 15–16 h a day 74/81 81/74 51.8 (20.9) 52.6 (19.3) 30 d Religious BMI, HOMA-IR, FINS, ALT, AST
Non-fasting
Rahimi et al. (17) Iran Comparative, double arm Ramadan fasting, 15–16 h a day 34/26 39/21 46.03 (11.72) 49.58 (10.96) 30 d Religious BW, BMI
Non-fasting
Ebrahimi et al. (14) Iran Comparative, double arm Ramadan fasting, 15–16 h a day 42/41 57/26 37.59 (7.06) 35.80 (7.33) 30 d Religious TG, TC, LDL-C, HDL-C
Non-fasting
Johari et al. (15) Malaysia RCT Modified alternate-day calorie restriction, 18 h alternate-day 33/10 33/10 45.33 (10.77) 52.60 (12.03) 8 w Modern BW, BMI, ALT, AST, TG, TC, LDL-C, HDL-C
Non-fasting

T, treatment; C, control; RCT, randomized controlled trial; M, male; F, female.

*

This study has two fasting intervention groups.